Dr Karin Schmitt joins Mursla as Chief Operating Officer
Mursla adds seasoned executive with a wealth of experience in rapid growth and product commercialisation to leadership team
News
Search
- Apr 13
- 2 min
Mursla unveils new bead-nanochip technology for ultrasensitive and high throughput exosome detection
Novel technology further establishes Mursla’s capabilities to uniquely analyse exosome biology for clinical translation
- Mar 29
- 3 min
Mursla gains mentorship from Roche Diagnostics for pilot study in cirrhotic/liver cancer patients
Access to Roche Diagnostics’ expertise in the UK secured in recognition of Mursla’s differentiated value proposition for liquid biopsy
- Mar 1
- 1 min
Mursla presents its new logo to better reflect its core technology
New logo symbolises the secretion of an exosome from its parental cell along with its markers of origin.
- Nov 17, 2021
- 4 min
Mursla announces key appointments to Advisory Board
Key opinion leaders in the fields of exosomes, liquid biopsy and liver disease support Mursla’s ambition
- Oct 20, 2021
- 3 min
Mursla granted patents for novel nanoelectronics detection system for exosomes
Mursla has been granted two patents for its novel nanoelectronics-based sensitive detection method for exosomes.
- Jun 15, 2020
- 1 min
Mursla helping on COVID-19
Mursla is dedicating resources to help improve COVID-19 diagnostics & therapeutics solutions. We are currently capitalising upon our...
- Oct 28, 2019
- 1 min
Cambridge Tech Awards 2019: Mursla among the #OneToWatch
Mursla was selected again as one of the most exciting tech companies to follow in the Cambridge cluster. https://www.cambridgeindependent...
- Mar 12, 2019
- 1 min
Award for innovation in Cambridgeshire and East of England
We are delighted to have won the #onetowatch award as one of the most innovative companies in Cambridgeshire and East of England. The...
Blog
.jpg)
ENG
FR
日本語
ENG
Want to partner with us?